PATENT CLAIM ANALYSIS

Application Number: 16161642
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "230500"]

Abstract:
The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.

Claim (Index 10):
The method of  claim 1 , the compound having the structure:

Metadata:
- Claim Count in Document: 80.0
- Percentile: 97.0
- Lexical Diversity: 1.05556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14549885', '15889494', '15621013', '15013218', '14487347']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.815934274267295
- 35 USC 102 Novelty (BERT): 0.6297574566511392
- Combined Prediction Score: 0.7973165925056794
- Mean Citation Score: 545.721512
- Max Citation Score: 671.1336
- Similarity Product: 501.5734409729004

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test